Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Individualizing primary prophylaxis in patients with hemophilia A and B, adherence and new products.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Jun 2023

Berrueco Rubén

Abstract excerpt

The purpose of prophylaxis in hemophilic patients is to prevent bleeding. The latest guidelines of the World Hemophilia Federation recommend that all patients with a severe hemorrhagic phenotype should receive prophylactic treatment, defined as the regular administration of therapeutic products (either factor concentrates or nonfactor replacement treatments). These products are aimed at preserving hemostasis and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hemophilia A
Share to Hemophilia B
Share to Hemorrhage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemostasis

Share to Phenotype

Source

Identifiers

PMID: 37254724
DOI: 10.1097/MBC.0000000000001200

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Individualizing primary prophylaxis in patients with hemophilia A and B, adherence and new products.PMID 37254724Read ↗

The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and ChallengesSemantic proximity Read ↗

Evolution of the Treatments for Hemophilia.Semantic proximity Read ↗

Diagnosis and management of hemophilia A and B.Semantic proximity Read ↗

Prophylaxis for severe hemophilia: experience from Europe and the United States.Semantic proximity Read ↗

Delphi Consensus Recommendations for the Definition of a Severe Bleeding Phenotype and Initiation of Prophylaxis in Patients With Non-Severe Haemophilia.Semantic proximity Read ↗

Navigation of the Hemophilia Drug Choice-Paralysis: A Quick User Guide to New and Existing TherapiesSemantic proximity Read ↗

Acquired hemophilia A: Updated review of evidence and treatment guidance.Semantic proximity Read ↗

Haemophilia.Semantic proximity Read ↗

[Hemophilia B replacement therapy drugs].Semantic proximity Read ↗

Emerging therapies for hemophilia: controversies and unanswered questionsSemantic proximity Read ↗

Factor VIII/factor IX prophylaxis for severe hemophilia.Semantic proximity Read ↗

The long and short of it: using the new factor products.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.